ALFA FinderBSE filing, NSE: ENNATURE. Summary written from the filing by ALFA Finder's alert engine.
Ennature Bio Pharma Ltd: key numbers
- Share price
- ₹208.85
- Market cap
- ₹466.6 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- Promoter holding
- 59.63%
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ennature Bio Pharma Ltd
All →Ennature Bio Pharma Other Announcement
Ennature Bio Pharma designated five senior managers (Heads/DGMs) as SMP per SEBI circular. This is a routine compliance intimation with no material business impact.
Ennature Bio Pharma Board Meeting Outcome
Ennature Bio Pharma's board approved adoption of new Articles of Association to align with SCRA Rules 1957 and group governance. The change is subject to shareholder approval.
Ennature Bio Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹4.9 Cr
Ennature Bio Pharma Ltd reported revenue from operations of ₹78.5 Cr (+45.1% YoY) and net profit of ₹4.9 Cr for Q2 FY27.
- Key figure
- Net profit ₹4.9 Cr
Ennature Bio Pharma Board Meeting Date
Ennature Bio Pharma will hold a board meeting on 12 November 2026 to consider unaudited second-quarter results ended September 2026. Trading window stays closed until 14 November.
Ennature Bio Pharma Capital Structure Change
Ennature Bio Pharma listed its equity shares on NSE and BSE on 4 November 2026. The company brings its API, biopolymer and nutraceutical businesses to public markets.
Other management change announcements
All →Fusion CX Management Change
Fusion CX appointed three directors, including Rakesh Sony and Narayanan Subramaniam as independent directors, effective 13 November 2026. Statutory and secretarial auditors were also appointed.
Autofurnish Management Change
Autofurnish Limited appointed Mr. Pulak Kumar Palit as Non-Executive Independent Director for 60 months, effective 12 November 2026. The appointment follows the board meeting outcome, with no monetary value involved.
- Execution
- 60 months
S A Tech Software India Management Change
S A Tech Software appointed Ms. Stuti Mehta as Company Secretary and Compliance Officer from December 7, 2026. The appointment is a key managerial personnel change.
Gokak Textiles Management Change
Gokak Textiles re-appointed Gautam Kumtakar as Executive Director (CEO-MD) for 60 months, effective 8 January 2027. The decision was taken at the 13 November 2026 board meeting.
CMS Info Systems Management Change
CMS Info Systems' Company Secretary and Compliance Officer Debashis Dey resigned effective 19 November 2026. The resignation cites career opportunities outside the organisation.
John Cockerill India Management Change
John Cockerill India appointed three additional directors effective 13 November 2026. Committee reconstitution followed, with shareholder approval due within three months.